Page last updated: 2024-10-23

baclofen and Parkinson Disease, Secondary

baclofen has been researched along with Parkinson Disease, Secondary in 5 studies

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research Excerpts

ExcerptRelevanceReference
"A Parkinsonian-like tremor can be induced by a combined application of chlorpromazine and pentobarbitone in cats."7.68Parkinsonian-like tremor induced by a combined application of chlorpromazine and pentobarbitone in cats with left-paw preference. ( Cankaya, A; Gepdiremen, A; Kutlu, N; Tan, U, 1992)
"A Parkinsonian-like tremor can be induced by a combined application of chlorpromazine and pentobarbitone in cats."3.68Parkinsonian-like tremor induced by a combined application of chlorpromazine and pentobarbitone in cats with left-paw preference. ( Cankaya, A; Gepdiremen, A; Kutlu, N; Tan, U, 1992)
"Baclofen, commonly used to reduce severe muscle spasms in patients with spinal cord injuries, is also active in the brain."3.66A possible neurochemical basis for the neuropsychiatric aspects of baclofen therapy. ( Keegan, DL; Kirby, AR; Richardson, JS, 1983)
" The trouble occurs or is worsened when neuroleptics are withdrawn and is reduced when dosage is increased; it responds to the theoretical model of denervation supersensitivity."2.36[Tardive dyskinesia induced by neuroleptics. A review of the literature]. ( Cottereau, MJ; Deniker, P; Diepart, E, 1979)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keegan, DL1
Richardson, JS1
Kirby, AR1
Halbhübner, K1
Herken, H1
Loos, D1
Diepart, E1
Cottereau, MJ1
Deniker, P1
Tan, U1
Gepdiremen, A1
Kutlu, N1
Cankaya, A1
Arthurs, B1
Flanders, M1
Codère, F1
Gauthier, S1
Dresner, S1
Stone, L1

Reviews

1 review available for baclofen and Parkinson Disease, Secondary

ArticleYear
[Tardive dyskinesia induced by neuroleptics. A review of the literature].
    L'Encephale, 1979, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Athetosis; Baclofen; Child; Chorea; Diag

1979

Other Studies

4 other studies available for baclofen and Parkinson Disease, Secondary

ArticleYear
A possible neurochemical basis for the neuropsychiatric aspects of baclofen therapy.
    The International journal of neuroscience, 1983, Volume: 20, Issue:3-4

    Topics: Adult; Baclofen; Bipolar Disorder; Brain; Delusions; Depressive Disorder; Dose-Response Relationship

1983
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
    Arzneimittel-Forschung, 1978, Volume: 28, Issue:10

    Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine;

1978
Parkinsonian-like tremor induced by a combined application of chlorpromazine and pentobarbitone in cats with left-paw preference.
    The International journal of neuroscience, 1992, Volume: 63, Issue:3-4

    Topics: Animals; Atropine; Baclofen; Biperiden; Cats; Chlorpromazine; Feedback; Female; Functional Lateralit

1992
Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1987, Volume: 22, Issue:1

    Topics: Baclofen; Blepharoptosis; Blepharospasm; Botulinum Toxins; Drug Evaluation; Eyelid Diseases; Female;

1987